NPI: 1194771030 · DOWAGIAC, MI 49047 · Medicare Defined Swing Bed Hospital Unit · NPI assigned 05/25/2006
Authorized official HOUGHTON, MARINA controls 20+ related entities in our dataset. Read more
| Authorized Official | HOUGHTON, MARINA (CFO) |
| NPI Enumeration Date | 05/25/2006 |
Other providers sharing the same authorized official: HOUGHTON, MARINA
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 30,194 | $854K |
| 2019 | 26,848 | $789K |
| 2020 | 21,882 | $935K |
| 2021 | 27,326 | $1.22M |
| 2022 | 22,513 | $1.04M |
| 2023 | 25,438 | $1.18M |
| 2024 | 14,033 | $861K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 11,827 | 11,255 | $1.89M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 6,366 | 6,009 | $1.43M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 3,623 | 3,425 | $1.33M |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 3,834 | 3,546 | $449K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 2,778 | 2,718 | $251K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1,912 | 1,016 | $232K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 6,206 | 1,621 | $178K |
| 96361 | Intravenous infusion, hydration; each additional hour | 2,749 | 2,504 | $109K |
| 71046 | Radiologic examination, chest; 2 views | 4,032 | 2,095 | $102K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1,028 | 545 | $95K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 2,649 | 2,568 | $93K |
| 70450 | Computed tomography, head or brain; without contrast material | 1,278 | 680 | $73K |
| 71045 | Radiologic examination, chest; single view | 2,850 | 1,511 | $69K |
| 96375 | Therapeutic injection; each additional sequential IV push | 2,045 | 1,714 | $66K |
| 80053 | Comprehensive metabolic panel | 11,975 | 10,826 | $35K |
| 84443 | Thyroid stimulating hormone (TSH) | 4,394 | 4,232 | $34K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 682 | 670 | $33K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 3,560 | 3,234 | $26K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 13,008 | 11,548 | $25K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 1,608 | 1,554 | $22K |
| 97161 | 398 | 391 | $21K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 511 | 263 | $20K |
| 80061 | Lipid panel | 2,014 | 2,001 | $19K |
| 72100 | 744 | 439 | $18K | |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 3,775 | 3,323 | $17K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1,481 | 1,452 | $15K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 1,130 | 1,090 | $15K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 1,130 | 1,090 | $15K |
| 83036 | Hemoglobin; glycosylated (A1C) | 2,866 | 2,780 | $14K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 122 | 118 | $14K |
| 82465 | 1,375 | 1,349 | $10K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 26 | 24 | $10K |
| G0378 | Hospital observation service, per hour | 12 | 12 | $8K |
| 36415 | Collection of venous blood by venipuncture | 9,004 | 8,274 | $7K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 513 | 505 | $7K |
| 73630 | 673 | 361 | $7K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | 379 | 193 | $6K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2,920 | 2,501 | $6K |
| 82947 | 330 | 235 | $6K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 58 | 49 | $6K |
| 73562 | 362 | 190 | $6K | |
| 83718 | 1,362 | 1,347 | $5K | |
| 83880 | 695 | 658 | $5K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 21 | 20 | $5K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1,844 | 1,760 | $5K |
| 84478 | 1,398 | 1,376 | $4K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 99 | 98 | $4K |
| 82607 | 611 | 585 | $4K | |
| 73610 | 504 | 264 | $4K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1,442 | 1,379 | $4K |
| 73130 | 498 | 257 | $4K | |
| 73030 | 283 | 149 | $3K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 1,026 | 924 | $3K |
| 84439 | 617 | 598 | $3K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 173 | 81 | $2K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1,664 | 1,498 | $2K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1,540 | 1,520 | $2K |
| 83690 | 2,354 | 2,181 | $2K | |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 51 | 40 | $2K |
| 93975 | 25 | 13 | $2K | |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 49 | 26 | $2K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 63 | 38 | $2K |
| 74018 | 158 | 86 | $2K | |
| 87186 | 657 | 603 | $2K | |
| 85610 | 1,747 | 1,509 | $1K | |
| 81001 | 3,767 | 3,567 | $936.41 | |
| 73110 | 61 | 27 | $893.72 | |
| 83735 | 1,107 | 975 | $865.66 | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 33 | 31 | $763.54 |
| 84481 | 87 | 86 | $555.06 | |
| 85027 | 197 | 190 | $547.58 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 536 | 521 | $531.50 |
| 82550 | 271 | 265 | $475.94 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 35 | 32 | $451.77 |
| 87581 | 21 | 20 | $450.99 | |
| 87486 | 21 | 20 | $450.99 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 648 | 453 | $449.09 |
| 81003 | 2,115 | 2,059 | $445.11 | |
| 72070 | 26 | 16 | $442.28 | |
| 84484 | 1,908 | 1,601 | $438.39 | |
| 81025 | 3,057 | 2,918 | $385.34 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | 39 | 38 | $368.82 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 1,387 | 892 | $336.14 |
| 85730 | 1,065 | 1,012 | $320.95 | |
| 82728 | 38 | 38 | $243.21 | |
| 87077 | 97 | 88 | $227.73 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 358 | 331 | $154.69 |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 15 | 14 | $138.80 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 1,748 | 1,703 | $136.88 |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 131 | 130 | $126.18 |
| J7030 | Infusion, normal saline solution , 1000 cc | 3,053 | 2,701 | $115.20 |
| 83540 | 40 | 38 | $113.74 | |
| 83605 | 457 | 398 | $76.07 | |
| 81002 | 34 | 33 | $74.36 | |
| 84702 | 25 | 24 | $66.22 | |
| 85652 | 52 | 50 | $53.43 | |
| 86140 | 29 | 25 | $53.20 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 782 | 610 | $52.59 |
| 87070 | 27 | 27 | $49.16 | |
| 82043 | 12 | 12 | $40.77 | |
| 85379 | 117 | 113 | $40.70 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 3,015 | 2,861 | $40.27 |
| 87634 | 119 | 118 | $31.80 | |
| 87088 | 16 | 15 | $30.15 | |
| 86431 | 12 | 12 | $23.10 | |
| 87040 | 58 | 39 | $22.32 | |
| 86038 | 12 | 12 | $17.75 | |
| 80143 | 64 | 60 | $15.44 | |
| 80179 | 64 | 60 | $15.44 | |
| 87807 | 75 | 75 | $6.51 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 2,515 | 2,263 | $1.94 |
| J1170 | Injection, hydromorphone, up to 4 mg | 193 | 173 | $1.67 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 162 | 151 | $1.34 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 128 | 105 | $0.85 |
| J2270 | Injection, morphine sulfate, up to 10 mg | 171 | 156 | $0.00 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 12 | 12 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 33 | 28 | $0.00 |
| 87254 | 227 | 141 | $0.00 | |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 16 | 15 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 16 | 15 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 97 | 91 | $0.00 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 399 | 375 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 73 | 68 | $0.00 |
| 96376 | 67 | 47 | $0.00 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 122 | 97 | $0.00 |
| 87280 | 16 | 16 | $0.00 | |
| J2060 | Injection, lorazepam, 2 mg | 33 | 28 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 15 | 12 | $0.00 |